Biomarkers And Neurological Outcome in Neonates 2

NCT ID: NCT04714775

Last Updated: 2021-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-05

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Follow-up of participants of BANON1 study at age of at least 2 years. BANON1 (ClinicalTrials.gov ID: NCT03357250): Validation of biomarkers based on 24 months neuro-developmental outcome data in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies and a preliminary human study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Follow-Up on neuro-developmental status of Study participants of BANON1. BANON1 (ClinicalTrials.gov ID: NCT03357250): The aim of the study is to validate the application of combinations of several laboratory parameters in early postnatal blood samples, for identification of infants, who will suffer from early abnormal neonatal neurological outcome, in a population at risk. The population at risk is defined as term and late preterm (\>36 weeks of gestation) human infants following perinatal hypoxia-ischemia with or without postnatal resuscitation, and where the combination of laboratory parameters is derived from a preliminary study performed in Turkey (AAMBI) using a metabolomics approach.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asphyxia Neonatorum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infants previously enrolled in BANON study

Exclusion Criteria

* Missing valid written informed parental consent
Minimum Eligible Age

22 Months

Maximum Eligible Age

48 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Tuebingen

OTHER

Sponsor Role collaborator

InfanDx AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ron Meyer

Role: STUDY_DIRECTOR

InfanDx AG

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Städtisches Krankenhaus Aschaffenburg

Aschaffenburg, , Germany

Site Status RECRUITING

Universitätsklinikum Carl Gustav Carus, Neonatologie

Dresden, , Germany

Site Status RECRUITING

Uniklinik Essen

Essen, , Germany

Site Status RECRUITING

Marienkrankenhaus

Hamburg, , Germany

Site Status RECRUITING

Universitätsklinikum Heidelberg

Heidelberg, , Germany

Site Status RECRUITING

Städtisches Klinikum Karlsruhe, Klinik für Kinder- und Jugendmedizin

Karlsruhe, , Germany

Site Status RECRUITING

Klinik für Kinder- und Jugendmedizin, Klinikum Dritter Orden,

München, , Germany

Site Status RECRUITING

Universitäts Kinderkrankenhaus und Perinatal Zentrum

München, , Germany

Site Status RECRUITING

Kinderklinik Dritter Orden

Passau, , Germany

Site Status RECRUITING

Klinik St. Hedwig

Regensburg, , Germany

Site Status RECRUITING

Universitätsklinikum Tübingen, Universiätsklinik für Kinder- u. Jugendmedizin

Tübingen, , Germany

Site Status RECRUITING

Cukurova University Hospital

Adana, , Turkey (Türkiye)

Site Status RECRUITING

University of Firat, Department of Pediatrics

Elâzığ, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ron Meyer

Role: CONTACT

+49 172 266 5552

Carola Steins-Rang, Dr.

Role: CONTACT

+49 22129271405

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christian Wieg, Dr. med.

Role: primary

Stefan Winkler, Dr. med.

Role: primary

Ursula Felderhoff, Prof.

Role: primary

Lutz Koch, Prof.

Role: primary

Johannes Pöschl, Prof.

Role: primary

Joachim Kühr, Prof.

Role: primary

Jochen Peters, Prof.

Role: primary

Andreas Flemmer, Prof.

Role: primary

Matthias Keller, Prof.

Role: primary

Jochen Kittel, Dr. med.

Role: primary

Axel Franz, Prof.

Role: primary

Hacer Yapicioglu-Yildizdas, Prof.

Role: primary

Erdal Taskin, Prof.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BANON2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Baby Brain Recovery Study
NCT05013736 RECRUITING
Serial Brain MRI in Hospitalized Preterm Infants
NCT06052865 ACTIVE_NOT_RECRUITING NA
Heart Beat Variability in Neonatal Encephalopathy
NCT03179553 ACTIVE_NOT_RECRUITING